Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for MCA Stenosis Hemodynamics
NCT01617538Phase 2Unknown
- Sponsor
- Capital Medical University
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin in middle cerebral artery stenosis (MCAS) and cerebral infarction, sponsored by Capital Medical University. Primary endpoints: Hemodynamics changes at 24 weeks and MCA stenosis at 24 weeks. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
middle cerebral artery stenosis (MCAS)cerebral infarction
Beyond the preview
Go deeper on NCT01617538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617538.